Wednesday, September 16, 2020 11:05:46 PM
A lot of us that got into the stock years ago believe in the Product.
I think it is cutting edge.
But still - no results or revenue coming up on 2 years since FDA approval.
Why should we believe a deal is imminent now..?
Their most basic product dumbed down is an external band-aid.
And that is a huge market.
Unfortunately a number of other products similar to that came on the scene while Norchi was dinking around with this and that.
That marketing deal was supposed to be their financial golden ticket to pay for all the work to get the really great products approved and sold.
And he blew it.
Look at the above example.
Great results.....
But it costs 4 doctor room visits to get it done.
This is still a great product.....
But I think dilution will take the stock price into the single digits.
In which case I might get back in.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM